Ident. | Authors (with country if any) | Title |
---|
000138 |
Jean-Christophe Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier-Beaupel [France] ; Anne-Marie Bonnet [France] ; Marie-Hélène Fiévet ; Agnès Bellanger ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; Mouna Ben Djebara [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean-Sébastien Hulot [France] ; Marie Vidailhet [France] | The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial |
000445 |
Suzanne Lesage ; Etienne Patin ; Christel Condroyer ; Anne-Louise Leutenegger ; Ebba Lohmann ; Nir Giladi ; Anat Bar-Shira ; Soraya Belarbi ; Nassima Hecham ; Pierre Pollak [Suisse] ; Anne-Marie Ouvrard-Hernandez ; Soraya Bardien ; Jonathan Carr ; Traki Benhassine ; Hiroyuki Tomiyama ; Caroline Pirkevi ; Tarik Hamadouche ; Ccile Cazeneuve [France] ; A. Nazli Basak ; Nobutaka Hattori ; Alexandra Drr [France] ; Meriem Tazir ; Avi Orr-Urtreger ; Lluis Quintana-Murci ; Alexis Brice [France] ; Yves Agid [France] ; A.-M. Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; Ph. Damier ; A. Deste ; A. Drr ; F. Durif ; E. Lohmann ; M. Martinez ; C. Penet ; Pierre Pollak [Suisse] ; Olivier Rascol [France] ; F. Tison ; C. Tranchant ; A. Troiano ; M. Vrin ; F. Viallet ; M. Vidailhet | Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans |
000477 |
Richard G. Brown [Royaume-Uni] ; Lucette Lacomblez [France] ; Bernard G. Landwehrmeyer [Allemagne] ; Thomas Bak [Royaume-Uni] ; Ingo Uttner [Allemagne] ; Bruno Dubois [France] ; Yves Agid [France] ; Albert Ludolph [Allemagne] ; Gilbert Bensimon [France] ; Christine Payan [France] ; Nigel P. Leigh [Royaume-Uni] | Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy |
000611 |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
000655 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
000699 |
Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne] | Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease |
000994 |
A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
000A45 |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France] | Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease |
000A79 |
Nathalie Chastan [France] ; Manh Cuong Do [France] ; Fabrice Bonneville [France] ; Frédéric Torny [France] ; Frédéric Bloch [France] ; G. W. Max Westby [France] ; Didier Dormont [France] ; Yves Agid [France] ; Marie-Laure Welter [France] | Gait and balance disorders in Parkinson's disease: Impaired active braking of the fall of centre of gravity |
000B99 |
N. Chastan [France] ; G. W. M. Westby [France] ; J. Yelnik [France] ; E. Bardinet [France] ; M. C. Do [France] ; Yves Agid [France] ; M. L. Welter [France] | Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease |
000E66 |
Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France] | Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom |
000F64 |
Valérie Cochen De Cock [France] ; Marie Vidailhet [France] ; Smaranda Leu [France] ; Antonio Texeira [France] ; Emmanuelle Apartis [France] ; Alexis Elbaz [France] ; Emmanuel Roze [France] ; Jean Claude Willer [France] ; Jean Philippe Derenne [France] ; Yves Agid [France] ; Isabelle Arnulf [France] | Restoration of normal motor control in Parkinson's disease during REM sleep |
001007 |
Michael W. M. Schüpbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltête [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
001236 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
001257 |
Pablo Iba N Ez ; Suzanne Lesage ; Ebba Lohmann ; Ste Phane Thobois ; Giuseppe De Michele [Italie] ; Michel Borg ; Yves Agid [France] ; Alexandra Du Rr ; Alexis Brice | Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa |
001418 |
W M M. Schüpbach [France] ; N. Chastan [France] ; M L Welter [France] ; J L Houeto [France] ; V. Mesnage [France] ; A M Bonnet [France] ; V. Czernecki [France] ; D. Maltête [France] ; A. Hartmann [France] ; L. Mallet [France] ; B. Pidoux [France] ; D. Dormont [France] ; S. Navarro [France] ; P. Cornu [France] ; A. Mallet [France] ; Yves Agid [France] | Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up |
001613 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
001730 |
Magali Periquet ; Morwena Latouche ; Ebba Lohmann ; Nina Rawal ; Giuseppe De Michele ; Sylvain Ricard ; He Lio Teive ; Vale Rie Fraix ; Marie Vidailhet ; David Nicholl ; Paolo Barone ; Nick W. Wood ; Salmo Raskin ; Jean-Franc Ois Deleuze ; Yves Agid [France] ; Alexandra Du Rr ; Alexis Brice | Parkin mutations are frequent in patients with isolated early‐onset parkinsonism |
001757 |
Ebba Lohmann [France] ; Magali Periquet [France] ; Vincenzo Bonifati [Italie] ; Nick W. Wood [Royaume-Uni] ; Giuseppe De Michele [Italie] ; Anne-Marie Bonnet [France] ; Valérie Fraix [France] ; Emmanuel Broussolle [France] ; Martin W. I. M. Horstink [Pays-Bas] ; Marie Vidailhet [France] ; Patrice Verpillat [France] ; Thomas Gasser [Allemagne] ; David Nicholl [Royaume-Uni] ; Hélio Teive [Brésil] ; Salmo Raskin [Brésil] ; Olivier Rascol [France] ; Alain Destée [France] ; Merle Ruberg [France] ; Francesca Gasparini [France] ; Giuseppe Meco [Italie] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France] | How much phenotypic variation can be attributed to parkin genotype? |
001A33 |
Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France] | Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease |
001A39 |
Martin Zarate-Lagunes [France] ; Wen-Jie Gu [France] ; Véronique Blanchard [France] ; Chantal Francois [France] ; Marie-Paule Muriel [France] ; Annick Mouatt-Prigent [France] ; Bruno Bonici [France] ; André Parent [France] ; Andreas Hartmann [France] ; Jérôme Yelnik [France] ; Georg A. Boehme [France] ; Laurent Pradier [France] ; Saliha Moussaoui [France] ; Baptiste Faucheux [France] ; Rita Raisman-Vozari [France] ; Yves Agid [France] ; Alexis Brice [France] ; Etienne C. Hirsch [France] | Parkin immunoreactivity in the brain of human and non‐human primates: An immunohistochemical analysis in normal conditions and in Parkinsonian syndromes |
001D09 |
D. Brassat [France] ; A. Durr [France] ; Yves Agid [France] ; A. Brice [France] | Génétique de la maladie de Parkinson |
001D25 |
P. Damier ; E. C. Hirsch ; Yves Agid [France] ; A. M. Graybiel | The substantia nigra of the human brain |
001D71 |
Marie-Paule Muriel [France] ; Véronique Bernard [France] ; Allan I. Levey [États-Unis] ; Ouahiba Laribi [France] ; D. Nora Abrous [France] ; Yves Agid [France] ; Bertrand Bloch [France] ; Etienne C. Hirsch [France] | Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease |
001F18 |
Murer [France] ; Gustavo Dziewczapolski [Argentine] ; Liliana B. Menalled [Argentine] ; M. Carmen García [Argentine] ; Yves Agid [France] ; Oscar Gershanik [Argentine] ; Rita Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
001F21 |
Johann Tassin ; Alexandra Dürr ; Thomas De Broucker [France] ; Nacer Abbas ; Vincenzo Bonifati ; Giuseppe De Michele ; Anne-Marie Bonnet ; Emmanuel Broussolle ; Pierre Pollak [France] ; Marie Vidailhet ; Michele De Mari ; Roberto Marconi [Italie] ; Soraya Medjbeur ; Allessandro Filla ; Giuseppe Meco ; Yves Agid [France] ; Alexis Brice [France] | Chromosome 6–Linked Autosomal Recessive Early-Onset Parkinsonism: Linkage in European and Algerian Families, Extension of the Clinical Spectrum, and Evidence of a Small Homozygous Deletion in One Family |
001F76 |
Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France] | Urinary disturbances in striatonigral degeneration and parkinson's disease: Clinical and urodynamic aspects |
002133 |
Philippe Anglade [France] ; Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Synaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's Disease |
002155 |
S. Hunot [France] ; F. Boissière [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Nitric oxide synthase and neuronal vulnerability in parkinson's disease |
002167 |
A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France] | Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? |
002175 |
S. Hunot [France] ; V. Bernard [France] ; B. Faucheux [France] ; F. Boissière [France] ; E. Leguern [France] ; C. Brana [France] ; P. Gautris [France] ; J. Guérin [France] ; B. Bloch [France] ; Yves Agid [France] ; C. Hirsch [France] | Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease |
002200 |
B. Leveugle [États-Unis] ; B. A. Faucheux ; C. Bouras [États-Unis] ; N. Nillesse ; G. Spik ; E. C. Hirsch ; Yves Agid [France] ; P. R. Hof [États-Unis] | Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease cases |
002283 |
F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine |
002344 |
Campion [France] ; M. Martinez [France] ; D. Hannequin ; A. Brice [France] ; C. Thomas-Anterion [France] ; A. Michon [France] ; M. C. Babron [France] ; B. Dubois [France] ; Y. Goas [France] ; A. Jaillard-Serradt [France] ; F. Ledoze [France] ; F. Pasquier [France] ; M. Puel [France] ; M. A. Zimmerman [France] ; M. Bellis [France] ; J. Mallet [France] ; Yves Agid [France] ; F. Clerget-Darpoux [France] | Characteristics of familial aggregation in early‐onset Alzheimer's disease: Evidence of subgroups |
002424 |
Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
002445 |
Annick Mouatt-Prigent [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease? |
002457 |
Jeswinder Sian ; David T. Dexter ; Andrew Lees (neurologue) [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner ; C. David Marsden [Royaume-Uni] | Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia |
002497 |
B. Dubois [France] ; B. Pillon [France] ; Yves Agid [France] | Détérioration des voies dopaminergiques et altérations des fonctions cognitives et motrices |
002554 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin [Espagne] ; J. Laguna [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [Espagne] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? |
002558 |
Patrick Vermersch ; Delacourte ; France Javoy-Agid [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] | Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins |
002771 |
R. Raisman-Vozari ; J.-A. Girault [États-Unis] ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France] | Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man |
002820 |
Scherman [France] ; Claire Desnos [France] ; François Darchen [France] ; Pierre Pollak [France] ; France Javoy-Agid [France] ; Yves Agid [France] | Striatal dopamine deficiency in parkinson's disease: Role of aging |
002864 |
Laurent Pierot [France] ; Claire Desnos [France] ; Jerome Blin [France] ; Rita Raisman [France] ; Daniel Scherman [France] ; France Javoy-Agid [France] ; Merle Ruberg [France] ; Yves Agid [France] | D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy |
002887 |
Maloteaux [Belgique] ; E. C. Laterre [Belgique] ; P. M. Laduron [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy |
002931 |
Dubois [France] ; François Danzé [France] ; Bernard Pillon [France] ; Guliana Cusimano [France] ; François Lhermitte [France] ; Yves Agid [France] | Cholinergic‐dependent cognitive deficits in Parkinson's disease |
002981 |
Merle Ruberg [France] ; François Rieger [France] ; Albert Villageois [France] ; Anne Marie Bonnet ; Yves Agid [France] | Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease |
002994 |
Roland Cash [France] ; Rita Raisman [France] ; Alain Ploska [France] ; Yves Agid [France] | High and low affinity [3H]imipramine binding sites in control and Parkinsonian brains |
002999 |
Etienne Hirsch [France] ; Merle Ruberg [France] ; Mireille Dardenne [France] ; Marie-Madeleine Portier ; France Javoy-Agid [France] ; Jean-Francois Bach [France] ; Yves Agid [France] | monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease |
002A08 |
L. Pique [France] ; S. Jegou ; X. Bertagna [France] ; F. Javoy-Agid ; D. Seurin [France] ; M. F. Proeschel [France] ; F. Girard [France] ; Yves Agid [France] ; H. Vaudry ; J. P. Luton [France] | Pro-opiomelanocortin peptides in the human hypothalamus: Comparative study between normal subjects and parkinson patients |
002A25 |
D. Rougemont ; J C Baron ; P. Collard ; P. Bustany ; D. Comar ; Yves Agid [France] | Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. |
002A78 |
Bernard Scatton ; France Javoy-Agid [France] ; Liliane Rouquier ; Bruno Dubois [France] ; Yves Agid [France] | Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease |
002A98 |
Bruno Dunois ; Merle Ruberg ; France Javoy-Agid ; Alain Ploska ; Yves Agid [France] | A subcortico-cortical cholinergic system is affected in Parkinson's disease |